| Company | SAPL | Symbol |
| Company Name | Sanofi-Aventis Pakistan Limited | Company Name |
| Sector | Pharma and Bio Tech | Sector |
| Avg EPS | Rs 21.29 | Average of past year end EPS's |
| Sector Average | Rs 19.85 | Sector average of the above |
| Avg EPS FV | Rs 224.09 | Fair Value (DCF) based on average of past year end EPS's |
| EPS | Rs 51.30 | Last four quarters EPS |
| Sector Average | Rs 31.22 | Sector average of the above |
| EPS FV | Rs 540.00 | Fair Value (DCF) based on last four quarters EPS |
| Current Price | Rs 459.74 | Last closing stock price |
| Updated | May 2013 | Data Month/Year |
| Div | Rs 12.50 | Total dividend paid during last four quarters |
| Sector Average | Rs 12.89 | Sector average of the above |
| Div FV | Rs 131.58 | Fair value (DD) based on total dividend paid during last four quarters |
| Avg Div | Rs 6.15 | Average of yearly dividends paid (including currently paid ones) |
| Sector Average | Rs 10.44 | Sector average of the above |
| Avg Div FV | Rs 64.74 | Fair value (DD) based on Average of yearly dividends paid (including current) |
| Avg | Rs 150.13 | Fair value (averaged of other fair values) |
| Upside | -67.34% | Upside potential (in percentage) based on the above Average. |
| Div Yield | 2.72% | Dividend yield |
| Sector Average | 4.18% | Sector average of the above |
| Book Value | Rs 181.55 | Book Value |
| Sector Average | Rs 190.24 | Sector average of the above |
| FV FCF/S | Rs -115.69 | Fair Value based on free cash flow per share |
| Outstanding Shares | 9,644,800 | Number of Outstanding Shares |
| Current Assets | Rs 3,920.00 | Currency in Millions of Pakistan Rupees |
| Total Liabilities | Rs 3,682.00 | Currency in Millions of Pakistan Rupees |
| NCAV/S | Rs 24.68 | Net Current Asset Value / Share |
| Total Assets | Rs 5,433.00 | Currency in Millions of Pakistan Rupees |
| Quarter | September 2012 | Data Quarter |
| CfO | Rs 21.00 | CASH FROM OPERATIONS (Millions of Rs) |
| FCF/S | Rs -10.99 | Free Cash Flow per Share |
| FCF/S Sector Avg | 14.79 | Sector Average FCF/S |
| P/E | 8.96 | Price over earnings ratio |
| P/E Sector Avg | 9.51 | Sector Average P/E |
| P/B | 2.53 | Price over book value ratio |
| P/B Sector Avg | 2.12 | Sector Average P/B |
| PR | 24.37 | Payout Ratio (in %) |
| PR Sector Avg | 40.43 | Sector average Payout Ratio (in %) |
| D/E Ratio | 210.28 | Debt / Equite ratio (%) |
| Sector D/E Ratio | 85.79 | Sector Debt / Equity ratio (%) |
| Price Performance | ||
| Last Trade Date | 21/05/2013 | |
| Last Trade Price | Rs 459.74 | |
| 3 Months Avg | Rs 398.35 | |
| 6 Months Avg | Rs 324.87 | |
| 9 Months Avg | Rs 274.62 | |
| 12 Months Avg | Rs 242.21 | |
| Score | -14 | cumulative +ve's, -ve's from above all |
Thursday, May 23, 2013
SAPL - Sanofi-Aventis Pakistan Limited - Company Analysis -23/05/2013
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment